Market Research Report
Analysis of the Cardiac Biomarker Diagnostics Market
|Published by||Frost & Sullivan||Product code||341834|
|Published||Content info||116 Pages
Delivery time: 1-2 business days
|Analysis of the Cardiac Biomarker Diagnostics Market|
|Published: September 30, 2015||Content info: 116 Pages||
This publication has been discontinued on January 14, 2020.
Emerging Biomarkers Disrupt and Spur Growth in the Heart Failure Segment
The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates that are driving this market, the increasing use of point-of-care testing devices at ambulatory and at clinical settings spurs this market in the region. The push towards a more patient centric and wholesome care places imaging companies that can provide a more comprehensive diagnostic product are at an advantage in this market.